J2850 HCPCS Level II code: Injection, secretin, synthetic, human, 1 microgram
J2850 is the HCPCS code for “Injection, secretin, synthetic, human, 1 microgram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2850Injection, secretin, synthetic, human, 1 microgram
Short description: Inj secretin synthetic human
HCPCS · United States
Medicare details
The indicators CMS publishes with J2850 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2006
Where J2850 sits
- 1J codesDrugs administered other than orally
- 2Active code J2850Injection, secretin, synthetic, human, 1 microgram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2850 mean?
J2850 is the HCPCS code for “Injection, secretin, synthetic, human, 1 microgram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2850?
CMS lists J2850’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2850
All J codesJ2804Injection, rifampin, 1 mgJ2805Injection, sincalide, 5 microgramsJ2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 microgramsJ2810Injection, theophylline, per 40 mgJ2820Injection, sargramostim (gm-csf), 50 mcgJ2840Injection, sebelipase alfa, 1 mgJ2860Injection, siltuximab, 10 mgJ2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mgJ2910Injection, aurothioglucose, up to 50 mgJ2916Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mgJ2919Injection, methylprednisolone sodium succinate, 5 mgJ2920Injection, methylprednisolone sodium succinate, up to 40 mg